- Home
- ATXI vs LTRY Comparison
ATXI vs LTRY Comparison
Compare ATXI & LTRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXI
- LTRY
- Stock Information
- Founded
- ATXI 2015
- LTRY 2015
- Country
- ATXI United States
- LTRY United States
- Employees
- ATXI N/A
- LTRY N/A
- Industry
- ATXI Biotechnology: Pharmaceutical Preparations
- LTRY Computer Software: Prepackaged Software
- Sector
- ATXI Health Care
- LTRY Technology
- Exchange
- ATXI Nasdaq
- LTRY Nasdaq
- Market Cap
- ATXI 3.0M
- LTRY 3.2M
- IPO Year
- ATXI 2017
- LTRY N/A
- Fundamental
- Price
- ATXI $1.85
- LTRY $0.30
- Analyst Decision
- ATXI
- LTRY
- Analyst Count
- ATXI 0
- LTRY 0
- Target Price
- ATXI N/A
- LTRY N/A
- AVG Volume (30 Days)
- ATXI 22.1K
- LTRY 201.4K
- Earning Date
- ATXI 11-14-2024
- LTRY 12-16-2024
- Dividend Yield
- ATXI N/A
- LTRY N/A
- EPS Growth
- ATXI N/A
- LTRY N/A
- EPS
- ATXI N/A
- LTRY N/A
- Revenue
- ATXI N/A
- LTRY $6,143,350.00
- Revenue This Year
- ATXI N/A
- LTRY N/A
- Revenue Next Year
- ATXI N/A
- LTRY N/A
- P/E Ratio
- ATXI N/A
- LTRY N/A
- Revenue Growth
- ATXI N/A
- LTRY 190.77
- 52 Week Low
- ATXI $1.60
- LTRY $0.22
- 52 Week High
- ATXI $26.48
- LTRY $7.01
- Technical
- Relative Strength Index (RSI)
- ATXI 30.21
- LTRY 42.75
- Support Level
- ATXI $1.80
- LTRY $0.31
- Resistance Level
- ATXI $1.88
- LTRY $0.34
- Average True Range (ATR)
- ATXI 0.11
- LTRY 0.04
- MACD
- ATXI -0.02
- LTRY 0.00
- Stochastic Oscillator
- ATXI 0.00
- LTRY 22.02
About ATXI Avenue Therapeutics Inc.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
About LTRY Lottery.com Inc.
Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.